Infosys, the software firm that counts Rishi Sunak’s wife among its shareholders, has hit back at critics following a backlash over the length of time it took to quit Russia. 

The Chancellor and Akshata Murty, daughter of Infosys founder Narayana Murthy, found themselves at the centre of a controversy after Ukrainian MP Lesia Vasylenko accused the family of benefiting from ‘blood money’, arguing that any company contributing to the Russian economy was supporting its invasion of Ukraine. 

Controversy: Chancellor Rishi Sunak and his wife Akshata Murty, daughter of Infosys founder Narayana Murthy

Controversy: Chancellor Rishi Sunak and his wife Akshata Murty, daughter of Infosys founder Narayana Murthy

Controversy: Chancellor Rishi Sunak and his wife Akshata Murty, daughter of Infosys founder Narayana Murthy

Links to the Sunaks, forced Infosys into the spotlight after it emerged that the business still had a presence in Moscow until May. 

But its president, Mohit Joshi, said claims that it hadn’t pulled out of Russia fast enough were unfair, adding that it had fewer than 100 people there and was only serving global clients. 

Speaking to the Mail at the World Economic Forum in Davos, he said: ‘We don’t think the criticism was fair. We’ve been recognised as one of the most ethical companies in the world.’ 

He denied the Chancellor played a part in his decision to quit Russia, saying: ‘The Government would never have dreamed of stepping in.’

#fiveDealsWidget .dealItemTitle#mobile {display:none} #fiveDealsWidget {display:block; float:left; clear:both; max-width:636px; margin:0; padding:0; line-height:120%; font-size:12px} #fiveDealsWidget div, #fiveDealsWidget a {margin:0; padding:0; line-height:120%; text-decoration: none; font-family:Arial, Helvetica ,sans-serif} #fiveDealsWidget .widgetTitleBox {display:block; float:left; width:100%; background-color:#af1e1e; } #fiveDealsWidget .widgetTitle {color:#fff; text-transform: uppercase; font-size:18px; font-weight:bold; margin:6px 10px 4px 10px; } #fiveDealsWidget a.dealItem {float:left; display:block; width:124px; margin-right:4px; margin-top:5px; background-color: #e3e3e3; min-height:200px;} #fiveDealsWidget a.dealItem#last {margin-right:0} #fiveDealsWidget .dealItemTitle {display:block; margin:10px 5px; color:#000; font-weight:bold} #fiveDealsWidget .dealItemImage, #fiveDealsWidget .dealItemImage img {float:left; display:block; margin:0; padding:0} #fiveDealsWidget .dealItemImage {border:1px solid #ccc} #fiveDealsWidget .dealItemImage img {width:100%; height:auto} #fiveDealsWidget .dealItemdesc {float:left; display:block; color:#004db3; font-weight:bold; margin:5px;} #fiveDealsWidget .dealItemRate {float:left; display:block; color:#000; margin:5px} #fiveDealsWidget .footerText a:hover{text-decoration: underline;} #fiveDealsWidget .footerSmall{font-size:10px; padding-top:10px;} @media (max-width: 635px) { #fiveDealsWidget a.dealItem {width:19%; margin-right:1%} #fiveDealsWidget a.dealItem#last {width:20%} } @media (max-width: 560px) { #fiveDealsWidget #desktop {display:none;} #fiveDealsWidget #mobile {display:block!important} #fiveDealsWidget a.dealItem {background-color: #fff; height:auto; min-height:auto} #fiveDealsWidget a.dealItem {border-bottom:1px solid #ececec; margin-bottom:5px; padding-bottom:10px} #fiveDealsWidget a.dealItem#last {border-bottom:0px solid #ececec; margin-bottom:5px; padding-bottom:0px} #fiveDealsWidget a.dealItem, #fiveDealsWidget a.dealItem#last {width:100%} #fiveDealsWidget .dealItemContent, #fiveDealsWidget .dealItemImage {float:left; display:inline-block} #fiveDealsWidget .dealItemImage {width:35%; margin-right:1%} #fiveDealsWidget .dealItemContent {width:63%} #fiveDealsWidget .dealItemTitle {margin: 0px 5px 5px; font-size:16px} #fiveDealsWidget .dealItemContent .dealItemdesc, #fiveDealsWidget .dealItemContent .dealItemRate {clear:both} }

This post first appeared on Dailymail.co.uk

You May Also Like

De La Rue faces Indian corruption investigation

De La Rue is embroiled in a corruption probe in India involving…

Is Astrazeneca’s for bid American rival a deal too far?

It was a moment of maximum peril for Astrazeneca.  The British drugs…

World Chess’ next move includes a £6.9m stock market float

World Chess is plotting a £6.9m (€8m) listing on the London Stock…

Tycoons seize control of UK’s largest pubs group Mitchells & Butlers

A group of super-rich tycoons based in the Caribbean has seized control…